课题基金 / 基金详情

Practical development of the lipid vesicle as surfactant assemblies having a functional molecular-recognition -toward to a cancer therapy in DDS-

Practical development of the lipid vesicle as surfactant assemblies having a functional molecular-recognition -toward to a cancer therapy in DDS-
脂质囊泡作为具有功能性分子识别功能的表面活性剂组装体的实际开发,用于 DDS 中的癌症治疗
批准号:
11793006
负责人:
KATO Keichi
金额:
$4.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for University and Society Collaboration
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The main purpose of this work is the new preparation of the lipid vesicles, which have a function of specific targeting to a cancer cell to apply to a cancer therapy in DDS : the vesicles are mainly composed of Span80 (sorbitan monooleate) and the stability is very excellent.First, as a targeting ligand to a cancer cell as "missile device" which was immobilized to the vesicle, new alga lectin was chosen. The alga lectin was extracted and purified from a red alga, Eucheuma serra. The lectin was abbreviated as ESA (Eucheuma serra agglutinin). The ESA associates with high-mannose type carbohydrate chain specifically. The ESA-imoobilized vesicle (abbreviated as ESA-vesicle) was found to specifically combine with cancer cells, such as human colon adenocarcinoma (colo201) and not to combine to MCF10-2A and Fibroblast as a normal cell lines. The ESA had an excellent heat-stability and the inhibition of the growth of a cancer cell. Thus, ESA can be applied to both the targeting ligand and canc … More er cell or the inhibitor of cancer-cell growth. The growth inhibition was also found to induce an apoptosis. The ESA-vesicle flew smoothly in the superior artery of rabbit.The in-vivo experiments on the injection of the ESA-vesicle into rats suggested no cytotoxic effect of the vesicle on the rats because of the rat's living during 5 weeks without decrease in the weight. Moreover, in the in-vivo experiments on the injection of the ESA-vesicle into the nude mouse carrying colo201, the growth inhibition of the colo201 was aiso observed. Thus, the ESA-vesicle is expected to using for the cancer therapy in DDS.Next, some kinds of antibodies as a "missile device" as mentioned above were also immobilized on the Span80 vesicle. The specifical combines of the immunovesicles with each targeting cell were successfully confirmed the tageting experiments in vitro. The transfection of the DNA or prasmid entrapped in the immunovesicles to the targeting cells were also confirmed.Thus, the above ESA-vesicles as well as an immunovesicle were expected to be applied to either DDS or gene transfection. Less
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
K.Kato, T.Sugahara, Y.Maruyama, N.Yoshimura, N.Tateishi, Y.Suzuki, A.Kawakubo, T.Sasaki: "Study of DDS for a cancer therapy applying lipid vesicle immobilizing Eucheuma Serra Lectin"Animal Cell Technology, Products from Cells, Cells as Products, Kluwer Ac
K.Kato、T.Sugahara、Y.Maruyama、N.Yoshimura、N.Tateishi、Y.Suzuki、A.Kawakubo、T.Sasaki:“应用脂质囊泡固定麒麟菜 Serra 凝集素进行癌症治疗的 DDS 的研究”动物细胞
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Sugahara, K.Kato, A.Fukuda, A.Yoshihiro, N.Yohimura, N.Tateishi, A.Kawakubo: "Application of the lipid vesicle immobilized Eucheuma serra lectin for target-specific drug derivery"Proc. of Biotechnology 2000 (The World Congress on Biotechnology). 2. 83-8
T.Sugahara、K.Kato、A.Fukuda、A.Yoshihiro、N.Yohimura、N.Tateishi、A.Kawakubo:“脂质囊泡固定麒麟菜凝集素在靶标特异性药物衍生中的应用”Proc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
加藤敬一, 菅原卓也, 佐々木毅, 丸山祐樹, 吉村和憲, 立石憲彦, 川久保明宏: "癌細胞への標的機能を有する脂質ベシクルの創製"化学工学シンポジウムシリーズ. 76. 230-238 (2001)
Keiichi Kato、Takuy​​a Sukawara、Takeshi Sasaki、Yuki Maruyama、Kazunori Yoshimura、Norihiko Tateishi、Akihiro Kawakubo:“具有癌细胞靶向功能的脂质囊泡的创建”化学工程研讨会系列。 76. 230-238 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
加藤敬一, 川嶋真一, 菅原卓也: "癌治療DDSへの利用を目指した脂質ベシクルの創製 -抗体を固定化したイムノベシクル-"ケミカルエンジニアリング. 45、6. 49-55 (2000)
Keiichi Kato、Shinichi Kawashima、Takuy​​a Sukawara:“用于癌症治疗 DDS 的脂质囊泡的创建 - 具有固定化抗体的免疫囊泡 -”化学工程 45, 6. 49-55 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
31
    海外基金